Outstanding Achievement Award

About the Award

The ASGCT Outstanding Achievement Award recognizes an ASGCT Member who has achieved a pioneering research success, a specific high impact accomplishment, or a lifetime of significant contributions to the field of gene and cell therapy. It is the Society’s highest honor. The ASGCT Outstanding Achievement Award recipient will be celebrated at the ASGCT 21st Annual Meeting in Chicago, IL in May 2018. The recipient will present a plenary lecture highlighting his/her scientific accomplishments that led to the Award.

Criteria and Nominations

Any ASGCT Member, other than a current Officer or member of the Nomination and Awards Committee, is eligible. Nominations letters must be 500 words or fewer and be submitted by no less than two ASGCT Members. Nominees will be notified and required to provide a CV or NIH bio-sketch.  
Nominations are due to the ASGCT Executive Office by December 15, 2017 and may be submitted directly to: awards@asgct.org.   


Maria-Grazia Roncarolo, MD, Stanford University School of Medicine, Stanford, CA
Cell and Gene Therapy for Genetic Immunodeficiencies:  Popping the Bubble

Seppo Yla-Herttuala, MD, PhD, FESC, University of Eastern Finland
Vascular Biology and Advances in Cardiovscular and Cancer Gene Therapy From Bench to Bedside

Bruce Sullenger, PhD, Duke University Medical Center, Durham, NC
Therapeutic Aptamers from HIV Gene Therapy to the Cath Lab and Cancer

Luigi Naldini, MD, PhD, University Vita-Salute San Raffaele
Lentiviral Vectors From Bench to Bedside: A Lifetime Journey

Mark A. Kay, MD, PhD Stanford University School of Medicine
Deciphering Vector and Non-coding RNA Biology: A New Frontier in Nucleic Acid based Therapies.

David A. Williams, MD Children's Hospital Boston, Boston, MA
25 Years in Translation: The Hematopoietic Microenvironment and HSC Gene Therapy

Malcolm K. Brenner, MD, PhD, Baylor College of Medicine, Houston, TX
Cell and Gene Therapy - Putting it Together

Katherine A. High, MD, The Children’s Hospital of Philadelphia, Philadelphia, PA
Gene Therapy for Genetic Disease: Hemophilia as a Paradigm

Inder Verma, PhD, The Salk Institute, La Jolla, CA
25 Years of Gene Therapy: Ups and Downs

R. Jude Samulski, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC
AAVolution of a Smart Virus

22nd Annual Meeting
April 29 – May 2 | Washington D.C.